Hyaluronan Oligosaccharides as a Potential Anticancer Therapeutic

Author(s): Bryan P. Toole , Shibnath Ghatak , Suniti Misra .

Journal Name: Current Pharmaceutical Biotechnology

Volume 9 , Issue 4 , 2008

Become EABM
Become Reviewer


Hyaluronan (HA) polysaccharide has differential effects on cells depending on polymer size. One of the more exciting findings is that small chains or oligosaccharides of HA (6-18 sugar units), but not large polymers, will kill many types of cancer cells by triggering apoptosis while leaving normal cells unaffected. Even chemoresistant cells become drug-sensitive when co-treated with HA oligosaccharides. Overall, these observations form the basis for new anticancer therapeutics.

Keywords: Cancer, metastasis, CD44, signaling, apoptosis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [249 - 252]
Pages: 4
DOI: 10.2174/138920108785161569
Price: $58

Article Metrics

PDF: 11